US antitrust regulators are concerned about health insurer Anthem’sproposed acquisition of Cigna and not sure the companies can offer enough concessions to maintain competition in the industry, The Wall Street Journal reported on Sunday.
Both companies have scheduled meetings this week with top US Department of Justice officials, the Journal reported, citing people familiar with the matter.
Some of the sources said the DOJ had not yet made a decision on whether to sue to block the deal.
Wall Street does not seem convinced the deal will go through, as evidenced in the wide spread between Anthem’s offer and Cigna’s share price. As of the market close on Friday, Cigna shares traded at a 32.5 percent discount to the offer, which has an equity value of about $44 billion.
Anthem announced plans to buy Cigna last summer. Also pending is Aetna’s acquisition of Humana which faces significant antitrust concern, as well. That deal is valued at about $34 billion.
Full Content: Seeking Alpha
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI